Jason R. Kelly, See remarks at Ginkgo Bioworks Holdings, Inc. (DNA), sold 300,000 shares at $2.47 ($723K) on 2023-07-19, disclosed to the SEC on 2023-07-21.
Scheduled sale ($723k) by See remarks under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.47 | 100,000 | $247K | 34.2% |
| 2 | $2.47 | 100,000 | $247K | 34.2% |
| 3 | $2.29 | 100,000 | $229K | 31.7% |
| Total | $2.41 avg | 300,000 | $723K | 100% |
| Filing → |
| DNA | SELL | 2023-12-22 | $353K | — | Filing → |
| DNA | SELL | 2023-12-15 | $595K | — | Filing → |
| DNA | SELL | 2023-12-08 | $263K | — | Filing → |